Latest updates for Aacr Rare Cancers Initiative

Fresh curated links around AACR Rare Cancers Initiative are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress
  • From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research
  • At the AACR Annual Meeting 2026, Cancer Grand Challenges Teams Explore How Cancer Forms and Evolves

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

aacr.org /1 month ago

The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress

At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cance...

Read source
aacr.org /1 month ago

From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research

At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed how monoclonal antibodies transformed lymphoma treatmen...

Read source
aacr.org /1 month ago

At the AACR Annual Meeting 2026, Cancer Grand Challenges Teams Explore How Cancer Forms and Evolves

At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay of mutations, promoting factors, and tissue-specific epigen...

Read source
aacr.org /3 weeks ago

From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance

The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next generation of cancer treatments. We spoke with Andrea Wang-Gil...

Read source
aacr.org /2 weeks ago

AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More

We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference, including investigational KRAS degraders, approaches...

Read source
aacr.org /4 weeks ago

Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development

During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR;...

Read source
bioengineer.org /1 day ago

Consensus Roadmap Guides Clinical Trials for Rare Childhood CNS Tumors

Rare childhood central nervous system tumours have exposed one of the most stubborn weaknesses in modern oncology: science can move faster than the clinical-trial systems needed to...

Read source
rna-seqblog.com /1 month ago

Single nucleus RNA sequencing identifies new treatment targets for rare sinonasal cancers

RNA sequencing reveals distinct cellular programs and therapeutic targets in rare sinonasal carcinomas, supporting precision oncology approaches tailored to specific tumor subtypes...

Read source
aacr.org /1 week ago

Smart Chemotherapy Gets Smarter: Advances in Antibody-drug Conjugates

Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New research has helped to revolutionize the drug class and de...

Read source
bioengineer.org /1 month ago

Dana-Farber Researchers Unveil Promising Phase 2 Results for Targeted Therapy in Rare Bile Duct Cancer

A Breakthrough in Targeted Therapy: Zenocutuzumab Offers Hope for Patients with Rare NRG1-Positive Cholangiocarcinoma Cholangiocarcinoma, a rare but aggressive malignancy originati...

Read source
aacr.org /1 month ago

FDA Approvals in Oncology: April-June 2026 

During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment options available for patients with breast cancer, urin...

Read source
aacr.org /1 week ago

AACR in the News: Cancer Disparities Progress Report and OMB Statement

A variety of national and local news outlets have highlighted AACR initiatives and experts in recent weeks. Learn about the news stories covering the findings from the AACR Cancer...

Read source
cafepharma.com /1 week ago

Rare Disease Hunger Games

Rare Disease Hunger Games Anonymous (not verified) Sun, 08/16/2026 - 03:35 field_thread_url https://cafepharma.com/boards/threads/rare-disease-hunger-games...

Read source
amrc.org.uk /6 days ago

World Cancer Research Fund

www.wcrf.org Twitter: @WCRF_UK and @wcrfint Primary research areas Cancer Grant types Early Career Fellowship, Clinical Study, Programme, Project (typically <4 years) Rese...

Read source
amrc.org.uk /4 weeks ago

Cancer Research UK

www.cancerresearchuk.org Twitter: @CR_UK Primary research areas Cancer Grant types Clinical trial, Early Career Fellowship, Mid Career Fellowship, Senior Fellowship, Travel an...

Read source
amrc.org.uk /3 weeks ago

Crohn’s in Childhood Research Association

www.cicra.org Twitter: @cicracharity Primary research areas Child health,  Inflammatory and immune system,  Oral and gastrointestinal Grant types Early Career Fellowship,  Pro...

Read source
aacr.org /1 month ago

Editors’ Picks, June 2026: Preventing Colorectal Cancer, Targeting Neural Cross-talk to Stop Glioblastoma Recurrence, an...

The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma recurrence, identifying patients with multiple myelom...

Read source
nytimes.com /1 month ago

‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That

A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.

Read source
amrc.org.uk /3 weeks ago

Pancreatic Cancer UK

www.pancreaticcancer.org.uk Twitter: @pancreaticcanuk Primary research areas Cancer Grant types Early Career Fellowship, Seed Funding/Pump-priming, Clinical Study, Travel, Pos...

Read source
amrc.org.uk /1 month ago

Cancer Research UK – Policy for research involving the recruitment of human participants

Published: July 2026 Summary  Enhancing inclusive research design and delivery is a key element of Cancer Research UK’s strategic approach to equality, divers...

Read source
bioengineer.org /1 month ago

KRAS Drugs Offer New Hope for Rare Appendix Cancer Treatment

In a groundbreaking development for appendix cancer treatment, researchers at The University of Texas MD Anderson Cancer Center have unveiled promising results targeting the mutant...

Read source
amrc.org.uk /3 weeks ago

Friends of EORTC

http://www.eortc.org Primary research areas Cancer Grant types Clinical Trial, Clinical Study, Research Centre, Fellowship, Project (typically <4 years), Infrastructure Res...

Read source
aacr.org /1 month ago

The Long Road to Receiving Care—Examining Cancer Disparities in Rural Areas 

The AACR Cancer Disparities Progress Report 2026 included an examination of the growing gap in cancer care between rural and urban areas. The report also featured the stories of se...

Read source
amrc.org.uk /2 weeks ago

Target Ovarian Cancer

www.targetovariancancer.org.uk Twitter: @TargetOvarian Primary research areas Cancer Grant types Project (typically <4 years) Research stage Translational research How t...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Aacr Rare Cancers Initiative

cafepharma.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

aacr.org

Recent coverage from public sources
Public source

amrc.org.uk

Recent coverage from public sources
Public source

nytimes.com

Recent coverage from public sources
Public source

rna-seqblog.com

Recent coverage from public sources
Public source